Literature DB >> 15366972

MMR vaccination and autism : what is the evidence for a causal association?

Kreesten M Madsen1, Mogens Vestergaard.   

Abstract

It has been suggested that vaccination with the measles-mumps-rubella (MMR) vaccine causes autism. The wide-scale use of the MMR vaccine has been reported to coincide with the apparent increase in the incidence of autism. Case reports have described children who developed signs of both developmental regression and gastrointestinal symptoms shortly after MMR vaccination.A review of the literature revealed no convincing scientific evidence to support a causal relationship between the use of MMR vaccines and autism. No primate models exist to support the hypothesis. The biological plausibility remains questionable and there is a sound body of epidemiological evidence to refute the hypothesis. The hypothesis has been subjected to critical evaluation in many different ways, using techniques from molecular biology to population-based epidemiology, and with a vast number of independent researchers involved, none of which has been able to corroborate the hypothesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15366972     DOI: 10.2165/00002018-200427120-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  60 in total

1.  MMR vaccination and autism.

Authors:  A J Wakefield
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

Review 2.  Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models.

Authors:  M Hornig; W I Lipkin
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

Review 3.  Brief report: medial temporal lobe and autism: a putative animal model in primates.

Authors:  J Bachevalier
Journal:  J Autism Dev Disord       Date:  1996-04

4.  Association between measles infection and the occurrence of chronic inflammatory bowel disease.

Authors:  B Ward; P DeWals
Journal:  Can Commun Dis Rep       Date:  1997-01-01

5.  Neurologic disorders after measles-mumps-rubella vaccination.

Authors:  Annamari Mäkelä; J Pekka Nuorti; Heikki Peltola
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

6.  Absence of measles virus in Crohn's disease.

Authors:  M Iizuka; O Nakagomi; M Chiba; S Ueda; O Masamune
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

7.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.

Authors:  J Bertrand; A Mars; C Boyle; F Bove; M Yeargin-Allsopp; P Decoufle
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

8.  Vaccinations and risk of central nervous system demyelinating diseases in adults.

Authors:  Frank DeStefano; Thomas Verstraeten; Lisa A Jackson; Catherine A Okoro; Patti Benson; Steven B Black; Henry R Shinefield; John P Mullooly; William Likosky; Robert T Chen
Journal:  Arch Neurol       Date:  2003-04

Review 9.  Borna disease virus (BDV)-induced model of autism: application to vaccine safety test design.

Authors:  K M Carbone; S A Rubin; M Pletnikov
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

View more
  5 in total

1.  Are there altered antibody responses to measles, mumps, or rubella viruses in autism?

Authors:  Jane E Libbey; Hilary H Coon; Nikki J Kirkman; Thayne L Sweeten; Judith N Miller; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

Review 2.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

3.  Expanding the Grading of Recommendations Assessment, Development, and Evaluation (Ex-GRADE) for Evidence-Based Clinical Recommendations: Validation Study.

Authors:  Linda Phi; Reem Ajaj; Manisha H Ramchandani; Xenia Mc Brant; Oluwadayo Oluwadara; Olga Polinovsky; David Moradi; Andre Barkhordarian; Pathu Sriphanlop; Margaret Ong; Amy Giroux; Justin Lee; Muniza Siddiqui; Nora Ghodousi; Francesco Chiappelli
Journal:  Open Dent J       Date:  2012-01-25

4.  Proposed toxic and hypoxic impairment of a brainstem locus in autism.

Authors:  Woody R McGinnis; Tapan Audhya; Stephen M Edelson
Journal:  Int J Environ Res Public Health       Date:  2013-12-11       Impact factor: 3.390

5.  Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.

Authors:  Thomas A Rasmussen; Martin R S Jørgensen; Stephanie Bjerrum; Søren Jensen-Fangel; Henrik Støvring; Lars Østergaard; Ole S Søgaard
Journal:  BMJ       Date:  2012-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.